Acceleron Pharma
XLRN
#1866
Rank
NZ$19.40 B
Marketcap
NZ$317.35
Share price
0.00%
Change (1 day)
15,351.61%
Change (1 year)

Market capitalization of Acceleron Pharma (XLRN)

Last known market cap: NZ$19.40 Billion

As of October 2026 Acceleron Pharma has a market cap of NZ$19.40 Billion. This makes Acceleron Pharma the world's 1866th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Acceleron Pharma from 2013 to 2022

End of year Market Cap

Year Marketcap Change
2022NZ$17.21 B7.58%
2021NZ$16.00 B49.8%
2020NZ$10.68 B155.45%
2019NZ$4.18 B39.24%
2018NZ$3.00 B11.11%
2017NZ$2.70 B94.38%
2016NZ$1.39 B-41.41%
2015NZ$2.37 B47.17%
2014NZ$1.61 B18.05%
2013NZ$1.36 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$1.167 T 5,916.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$308.83 B 1,491.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$447.29 B 2,204.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
NZ$169.60 B 773.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
NZ$54.42 M-99.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
NZ$37.11 M-99.81%๐Ÿ‡บ๐Ÿ‡ธ USA
bluebird bio
BLUE
NZ$86.4 M-99.55%๐Ÿ‡บ๐Ÿ‡ธ USA